search icon
  • Print
  • ShareThis
  • Text Size

RSS Feed Print Category View
Gilead applies for FDA approval for Sofosbuvir
ThomasKim
Posted: Tuesday, April 9, 2013 1:36 PM
Joined: 2/20/2013
Posts: 40


"Gilead Sciences moved up again in the hepatitis C race. With a bunch of companies hurrying along all-oral programs, Gilead has taken an application to the FDA for approval of its hep C pill sofosbuvir  (GS-7977), positioning itself to become the first pharma group with a completely oral regimen on the U.S. market."

To read more: http://www.fiercebiotech.com/story/gilead-quickly-asks-fda-blockbuster-hep-c-approval/2013-04-08#ixzz2PzMX0oPz
 

| HIVMA | Contact Us

© Copyright IDSA 2014 Infectious Diseases Society of America

Full Site Mobile Site